BLTE Competitors & Alternatives
Compare Belite Bio Inc ADR with similar stocks in the same industry
Biotechnology
BLTE
Main Stock$159.16
Tradestie Score
52
Market Cap
$2.41B
Analyst Upside
+32.9%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$63.97
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$81.36
|
$6.64B | - | 48 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$117.38
|
$6.38B | - | 51 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$23.52
|
$6.03B | - | 55 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$52.34
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$100.28
|
$5.95B | - | 55 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$207.75
|
$5.92B | - | 56 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$33.78
|
$5.80B | 12.1 | 56 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$262.26
|
$5.20B | 38.1 | 55 | Compare |
More BLTE Analysis
Data updated: May 01, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry